Une thérapie ciblant l’inflammasome pourrait prévenir les issues défavorables de grossesse au cours de l’intervillite chronique histiocytaire récurrente d’étiologie indéterminée

Aurélien Mattuizzi, Fanny Sauvestre, T. Fargeix, W. Eoghann, Claire Leibler, Marine Cargou, N. Dugot-Senan, Isabelle Douchet, Dorothée Duluc, Cécile Contin‐Bordes, M.E. Truchetet, C. Richez, Édouard Forcade, P. Duffau, J.-F. Viallard, Loı̈c Sentilhes, Patrick Blanco, E. Lazaro
In: La Revue de Médecine Interne · 2024 · vol. 45 , pp. A368–A369 · doi:10.1016/j.revmed.2024.10.342 · W4404761525
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by qwen3.7-flash, 2026-08-26 ⓘ

The title suggests that a therapy targeting the inflammasome might prevent adverse pregnancy outcomes in cases of recurrent idiopathic histiocytic intervillitis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-09-20T06:29:17.529187+00:00
License: CC0 · commercial use OK